On Thursday, the FDA announced that it would grant GSK a fast track designation for its gonorrhea vaccine. The fast track process expedites the review process for drugs used to treat serious conditions...
Last week, on June 20, 2023, the United States Food and Drug Administration (FDA) launched a pilot program to reduce the risk of laboratory-developed tests to identify cancer biomarkers. The program...
Although drug-checking tools such as fentanyl test strips have been championed as critical harm-reduction tools in the opioid epidemic, additional data and research are required to assess their...
An mRNA vaccine produced by Moderna and Merck reduced the risk of skin cancer metastasis or death by 65%, according to clinical trial results shared at the 2023 session of the American Society of...
An open-label, randomized, noninferiority trial published in the New England Journal of Medicine revealed that ketamine and electroconvulsive therapy (ECT) were equally effective at managing...
While not a new concept, drug rationing across the United States has become an increasingly critical issue. In another tale about the dangers of high prescription drug costs, researchers published an...
On May 18, 2023, the United States Food and Drug Administration (FDA) approved RINVOQ, manufactured by Abbvie, as a once-daily treatment for adults with moderate or severely active Crohn’s...
Adding to the significant progression of mRNA vaccines in cancer care, Memorial Sloan Kettering Cancer Center (MSKCC) researchers have announced promising results from a phase 1 clinical trial using...
Yesterday, the United States Department of Agriculture (USDA) conditionally licensed an oral vaccine for Borrelia burgdorferi, the bacteria that causes Lyme disease. LymeShield, the product...
A recent study published in the Annals of Neurology identified a link between sleeping pill use and lowered levels of Alzheimer's disease protein. Protein buildups and plaques identified in...
On April 24, 2023, researchers published the results of a cohort study analyzing the effect of neutralizing monoclonal antibodies (nMABs) on patients with COVID-19, noting significantly improved...
On April 18, 2023, JAMA Network Open published an article linking stimulant prescription rates for ADGD to teen drug misuse. The study analyzed the medical and nonmedical use of prescription stimulants...
On April 3, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that they submitted Biological License Applications (BLAs) for an investigational treatment using exagamglogene autotemcel...
An article published in the New England Journal of Medicine found that post-exposure doxycycline reduces sexually transmitted infection (STI) rates by two-thirds. The study found that men who have sex...
In a study published in Nature on March 15, 2023, researchers achieved complete or nearly complete remission in 18 patients with KMT2A-rearranged or NPMI-mutant leukemia. The phase 1 clinical trial...
In a recent research letter published in JAMA Network Open, Chris A. Rees, MD, MPH, and his colleagues analyzed how pediatric clinical trial results are disseminated or made publicly available. Rees...
On Tuesday, Pfizer announced that the FDA accepted for review its Biologics License Application (BLA) for the company’s respiratory syncytial virus (RSV) vaccine candidate RSVpreF. Depending on...
A recent National Center for Health Statistics (NCHS) analysis determined that 18.4% of adults in the United States took a sleep medication to fall or stay asleep in the past 30 days. The study...
Despite common misconceptions, researchers published an article in JAMA Network Open noting that buprenorphine overdose-related deaths did not increase during the COVID-19 pandemic when providers were...
A publication in JAMA Network Open found that folate, vitamin B6, and vitamin B12 intake and serum levels are inversely related to metabolic syndrome (MetS) incidence, with higher intake levels...
